{
    "Title": "Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas\u2019 disease drug discovery",
    "URL": "https://doi.org/10.1371/journal.pntd.0006612",
    "Published": "July 12, 2018",
    "Subject_Areas": [
        "Trypanosoma cruzi",
        "Trypomastigotes",
        "Parasitic diseases",
        "Vero cells",
        "Amastigotes",
        "Cloning",
        "Polymerase chain reaction",
        "Drug therapy"
    ],
    "Authors": {
        "Lorna M. MacLean": [
            "Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom"
        ],
        "John Thomas": [
            "Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom"
        ],
        "Michael D. Lewis": [
            "London School of Hygiene & Tropical Medicine, London, United Kingdom"
        ],
        "Ignacio Cotillo": [
            "GlaxoSmithKline, Diseases of the Developing World, Tres Cantos, Madrid, Spain"
        ],
        "David W. Gray": [
            "Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom"
        ],
        "Manu De Rycker": [
            "Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, United Kingdom"
        ]
    }
}